Riggs Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,877
| Closed | -$1.46M | – | 517 |
|
|
2025
Q2 | $1.46M | Buy |
1,877
+65
| +4% | +$50.5K | 0.36% | 63 |
|
|
2025
Q1 | $1.5M | Sell |
1,812
-1,258
| -41% | -$1.05M | 0.43% | 60 |
|
|
2024
Q4 | $2.38M | Buy |
3,070
+3
| +0.1% | +$2.48K | 0.63% | 49 |
|
|
2024
Q3 | $2.72M | Sell |
3,067
-6
| -0.2% | -$5.39K | 0.74% | 46 |
|
|
2024
Q2 | $2.78M | Sell |
3,073
-24
| -0.8% | -$19.2K | 0.83% | 41 |
|
|
2024
Q1 | $2.41M | Sell |
3,097
-134
| -4% | -$95.4K | 0.7% | 47 |
|
|
2023
Q4 | $1.88M | Buy |
3,231
+868
| +37% | +$507K | 0.6% | 53 |
|
|
2023
Q3 | $1.27M | Buy |
2,363
+3
| +0.1% | +$1.55K | 0.45% | 60 |
|
|
2023
Q2 | $1.11M | Buy |
2,360
+2,181
| +1,218% | +$915K | 0.39% | 61 |
|
|
2023
Q1 | $61.5K | Buy |
179
+60
| +50% | +$20.2K | 0.02% | 126 |
|
|
2022
Q4 | $43.5K | Buy |
119
+100
| +526% | +$35.5K | 0.02% | 140 |
|
|
2022
Q3 | $6K | Hold |
19
| – | – | ﹤0.01% | 249 |
|
|
2022
Q2 | $6K | Sell |
19
-245
| -93% | -$73.5K | ﹤0.01% | 229 |
|
|
2022
Q1 | $76K | Hold |
264
| – | – | 0.02% | 133 |
|
|
2021
Q4 | $73K | Sell |
264
-9
| -3% | -$2.28K | 0.02% | 144 |
|
|
2021
Q3 | $63K | Buy |
273
+28
| +11% | +$6.91K | 0.02% | 138 |
|
|
2021
Q2 | $56K | Buy |
+245
| New | +$49.2K | 0.02% | 149 |
|
|
2020
Q4 | – | Sell |
-1,040
| Closed | -$92K | – | 287 |
|
|
2020
Q3 | $92K | Buy |
1,040
+500
| +93% | +$77.4K | 0.04% | 86 |
|
|
2020
Q2 | $88K | Hold |
540
| – | – | 0.04% | 80 |
|
|
2020
Q1 | $74K | Hold |
540
| – | – | 0.05% | 79 |
|
|
2019
Q4 | $71K | Hold |
540
| – | – | 0.03% | 109 |
|
|
2019
Q3 | $60K | Hold |
540
| – | – | 0.03% | 110 |
|
|
2019
Q2 | $60K | Hold |
540
| – | – | 0.03% | 111 |
|
|
2019
Q1 | $70K | Buy |
+540
| New | +$65.7K | 0.05% | 94 |
|
|
2016
Q4 | – | Sell |
-31
| Closed | -$2K | – | 274 |
|
|
2016
Q3 | $2K | Hold |
31
| – | – | ﹤0.01% | 246 |
|
|
2016
Q2 | $2K | Hold |
31
| – | – | ﹤0.01% | 240 |
|
|
2016
Q1 | $2K | Hold |
31
| – | – | ﹤0.01% | 233 |
|
|
2015
Q4 | $3K | Hold |
31
| – | – | ﹤0.01% | 233 |
|
|
2015
Q3 | $3K | Sell |
31
-60
| -66% | -$5.07K | ﹤0.01% | 226 |
|
|
2015
Q2 | $8K | Buy |
91
+60
| +194% | +$4.57K | ﹤0.01% | 234 |
|
|
2015
Q1 | $2K | Hold |
31
| – | – | ﹤0.01% | 273 |
|
|
2014
Q4 | $2K | Hold |
31
| – | – | ﹤0.01% | 268 |
|
|
2014
Q3 | $2K | Buy |
+31
| New | +$1.96K | ﹤0.01% | 269 |
|
Other funds holding LLY
Riggs Asset Management's LLY Position: Q3 2025 in Review
Riggs Asset Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 1,877 shares — an estimated $1.46M sold.
Riggs Asset Management first reported a position in LLY in Q3 2014 and held it in 33 quarters. The position peaked at $2.78M in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.
- Riggs Asset Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
- Riggs Asset Management sold 1,877 Eli Lilly shares in Q3 2025, an estimated $1.46M.
- Riggs Asset Management first reported a position in Eli Lilly in Q3 2014 and held it in 33 quarters.
- Riggs Asset Management's Eli Lilly position peaked at $2.78M in Q2 2024.
- 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.
Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.